Tuesday, May 16, 2017

US FDA News: Canagliflozin (Invokana, Invokamet): Drug Safety Communication - Increased Risk of Leg and Foot Amputations

New warnings, including a Boxed Warning, to be added to the canagliflozin drug labels.
Read more: Canagliflozin (Invokana, Invokamet): Drug Safety Communication - Increased Risk of Leg and Foot Amputations